These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10392410)

  • 21. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
    Kreyenbuhl JA; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
    Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic treatment by the established psychiatrist. A report of experiences].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 1998 Nov; 25(6):284-5. PubMed ID: 9885840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential disparities in the management of schizophrenia in the United States.
    Rost K; Hsieh YP; Xu S; Menachemi N; Young AS
    Psychiatr Serv; 2011 Jun; 62(6):613-8. PubMed ID: 21632729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder.
    Fleck DE; Hendricks WL; DelBello MP; Strakowski SM
    J Clin Psychiatry; 2002 Aug; 63(8):658-64. PubMed ID: 12197445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups.
    Emsley RA; Roberts MC; Rataemane S; Pretorius J; Oosthuizen PP; Turner J; Niehaus DJ; Keyter N; Stein DJ
    J Clin Psychiatry; 2002 Jan; 63(1):9-14. PubMed ID: 11841075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia.
    Lawson W; Johnston S; Karson C; Offord S; Docherty J; Eramo A; Kamat S; Blanchette CM; Carson W; Nasrallah HA
    Ann Clin Psychiatry; 2015 Nov; 27(4):242-52. PubMed ID: 26554365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of patient race and ethnicity on clinical assessment in patients with affective disorders.
    Gara MA; Vega WA; Arndt S; Escamilla M; Fleck DE; Lawson WB; Lesser I; Neighbors HW; Wilson DR; Arnold LM; Strakowski SM
    Arch Gen Psychiatry; 2012 Jun; 69(6):593-600. PubMed ID: 22309972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
    Opolka JL; Rascati KL; Brown CM; Gibson PJ
    Psychiatr Serv; 2004 Feb; 55(2):151-6. PubMed ID: 14762239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.
    Citrome L; Stauffer VL; Chen L; Kinon BJ; Kurtz DL; Jacobson JG; Bergstrom RF
    J Clin Psychopharmacol; 2009 Jun; 29(3):278-83. PubMed ID: 19440083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.
    Valenstein M; Copeland LA; Owen R; Blow FC; Visnic S
    J Clin Psychiatry; 2001 Jul; 62(7):545-51. PubMed ID: 11488366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia.
    Ruiz S; Chu P; Sramek J; Rotavu E; Herrera J
    Mt Sinai J Med; 1996; 63(5-6):306-9. PubMed ID: 8898532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.
    Sramek J; Roy S; Ahrens T; Pinanong P; Cutler NR; Pi E
    Hosp Community Psychiatry; 1991 Jun; 42(6):590-2. PubMed ID: 1677921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative doses and costs of antipsychotic medication.
    Davis JM
    Arch Gen Psychiatry; 1976 Jul; 33(7):858-61. PubMed ID: 8024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnicity and psychotropic drugs.
    Bond WS
    Clin Pharm; 1991 Jun; 10(6):467-70. PubMed ID: 1676623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.
    Meyer JM; Rosenblatt LC; Kim E; Baker RA; Whitehead R
    J Clin Psychiatry; 2009 Mar; 70(3):318-25. PubMed ID: 19192469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients.
    Herbeck DM; West JC; Ruditis I; Duffy FF; Fitek DJ; Bell CC; Snowden LR
    Psychiatr Serv; 2004 Jun; 55(6):677-84. PubMed ID: 15175466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic drug utilisation for acute schizophrenia.
    Razali MS; Hasanah CI
    Singapore Med J; 1996 Dec; 37(6):611-3. PubMed ID: 9104062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.